ArticleInternational journal of molecular medicine2025
[Corrigendum] Pharmacokinetics and antitumor efficacy of DSPE‑PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug‑resistant glioma cells.
Article in International journal of molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following the publication of the above article, an interested reader drew to the Editor's attention that data in certain of the figures appeared to be strikingly similar to that included in three other articles that had been contributed to other publications by the same research group. After having investigated the matter in the Editorial Office in conjunction with the authors, it transpired that certain of the flow cytometric (FCM) data featured in Fig. 4C on p. 697 had been placed erroneously in the published version of this figure, and were duplicates of data featured correctly/as intended in another one of this group's papers. Since the cell experiments in both studies were conducted simultaneously, the subsequent cell growth pictures were also taken at the same time, and the data were inadvertently mislabelled. Upon reviewing their data, the authors realized that the images of the QUE‑NLs (50 μM), QUE‑NLs (100 μM) and QUE‑NLs (200 μM) administration groups in Fig. 4C were the FCM plots that had been featured incorrectly in this figure (as indicated by the green labels in the corrected version of Fig. 4, which is shown on the next page). Furthermore, the cell growth images shown in Fig. 4B for the 'DMSO' and 'Control‑NLs' experiments had also been assembled incorrectly in this figure; the correct images for the 'DMSO' and 'Control‑NLs' data panels are also highlighted by the green labels in the corrected version of Fig. 4 on the next page. The authors can confirm that the errors made in assembling this figure did not have any significant impact on either the results or the conclusions reported in this study, and all the authors agree with the publication of this Corrigendum. The authors are grateful to the Editor of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.